BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11120800)

  • 21. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
    Nayak BP; Sailaja G; Jabbar AM
    J Virol; 2003 Oct; 77(20):10850-61. PubMed ID: 14512535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus.
    McAdam AJ; Farkash EA; Gewurz BE; Sharpe AH
    J Virol; 2000 Jan; 74(1):203-8. PubMed ID: 10590107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines.
    Rice J; Elliott T; Buchan S; Stevenson FK
    J Immunol; 2001 Aug; 167(3):1558-65. PubMed ID: 11466377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen.
    Tsuji T; Hamajima K; Ishii N; Aoki I; Fukushima J; Xin KQ; Kawamoto S; Sasaki S; Matsunaga K; Ishigatsubo Y; Tani K; Okubo T; Okuda K
    Eur J Immunol; 1997 Mar; 27(3):782-7. PubMed ID: 9079822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
    Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
    J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
    Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
    J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines.
    Iwasaki A; Stiernholm BJ; Chan AK; Berinstein NL; Barber BH
    J Immunol; 1997 May; 158(10):4591-601. PubMed ID: 9144471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.
    Barnett SW; Rajasekar S; Legg H; Doe B; Fuller DH; Haynes JR; Walker CM; Steimer KS
    Vaccine; 1997 Jun; 15(8):869-73. PubMed ID: 9234536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H3 enhances tumor immunity in vivo by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells.
    Luo L; Chapoval AI; Flies DB; Zhu G; Hirano F; Wang S; Lau JS; Dong H; Tamada K; Flies AS; Liu Y; Chen L
    J Immunol; 2004 Nov; 173(9):5445-50. PubMed ID: 15494491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B cell responses to a peptide epitope. IX. The kinetics of antigen binding differentially regulates costimulatory capacity of activated B cells.
    Vijayakrishnan L; Natarajan K; Manivel V; Raisuddin S; Rao KV
    J Immunol; 2000 Jun; 164(11):5605-14. PubMed ID: 10820235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo.
    Sigal LJ; Reiser H; Rock KL
    J Immunol; 1998 Sep; 161(6):2740-5. PubMed ID: 9743331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen.
    Allen TM; Vogel TU; Fuller DH; Mothé BR; Steffen S; Boyson JE; Shipley T; Fuller J; Hanke T; Sette A; Altman JD; Moss B; McMichael AJ; Watkins DI
    J Immunol; 2000 May; 164(9):4968-78. PubMed ID: 10779808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential requirements for expression of CD80/86 and CD40 on B cells for T-dependent antibody responses in vivo.
    Lumsden JM; Williams JA; Hodes RJ
    J Immunol; 2003 Jan; 170(2):781-7. PubMed ID: 12517941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective induction of high avidity CTL by altering the balance of signals from APC.
    Oh S; Hodge JW; Ahlers JD; Burke DS; Schlom J; Berzofsky JA
    J Immunol; 2003 Mar; 170(5):2523-30. PubMed ID: 12594278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HIV env immunities elicited by nucleic acid vaccines.
    Shiver JW; Davies ME; Yasutomi Y; Perry HC; Freed DC; Letvin NL; Liu MA
    Vaccine; 1997 Jun; 15(8):884-7. PubMed ID: 9234539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.
    Horner AA; Datta SK; Takabayashi K; Belyakov IM; Hayashi T; Cinman N; Nguyen MD; Van Uden JH; Berzofsky JA; Richman DD; Raz E
    J Immunol; 2001 Aug; 167(3):1584-91. PubMed ID: 11466380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
    Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K
    Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.